Specialty pharmacies: What are they, and how do they affect drug costs?
Specialty pharmacies have grown from a niche industry into a huge PBM moneymaker.
The latest developments in PBMs & reimbursement, tracking policy changes and industry innovations driving today's healthcare conversation.
Specialty pharmacies have grown from a niche industry into a huge PBM moneymaker.
The Consolidated Appropriations Act, passed in February, included several significant reforms for PBMs.
Decades ago, PBMs were independent operators, but now, the biggest ones are vertically integrated with healthcare conglomerates.
The law is another step in an escalating national effort to curb vertical integration.
Alternatives are enticing, but change has proven to be difficult.
Ritu Malhotra became president of alternative PBM Illuminate Rx in January.
A new bipartisan spending bill looks to create greater transparency within the PBM space.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.